Estela Paz Artal-rekin lankidetzan egindako argitalpenak (15)

2024

  1. A personalised delisting strategy enables successful kidney transplantation in highly sensitised patients with preformed donor-specific anti HLA antibodies

    HLA, Vol. 103, Núm. 6

2021

  1. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

2017

  1. Complement C3F allotype synthesized by liver recipient modifies transplantation outcome independently from donor hepatic C3

    Clinical Transplantation, Vol. 31, Núm. 1

  2. The presence of pretransplant antiphospholipid antibodies iga anti-b-2-glycoprotein i as a predictor of graft thrombosis after renal transplantation

    Transplantation, Vol. 101, Núm. 3, pp. 597-607

2016

  1. High proportion of CD95+ and CD38+ in cultured CD8+ T cells predicts acute rejection and infection, respectively, in kidney recipients

    Transplant Immunology, Vol. 34, pp. 33-41

2015

  1. Association of early kidney allograft failure with preformed IgA antibodies to β2-glycoprotein I

    Journal of the American Society of Nephrology, Vol. 26, Núm. 3, pp. 735-745

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

  2. Renal transplantation dramatically reduces IgA anti-beta-2-glycoprotein i antibodies in patients with endstage renal disease

    Journal of Immunology Research, Vol. 2014

2012

  1. Complement C3 genotyping of slow and fast variants by real time PCR-high resolution melting

    European Journal of Inflammation, Vol. 10, Núm. 3, pp. 329-334

  2. Informe del Taller Ibérico de Histocompatibilidad 2012. Componente de estandarización de resultados de anticuerpos anti-HLA mediante ensayo en fase sólida

    Inmunologia

2009

  1. An In Vitro Model of Cell Transplantation for Evaluation of Cell Engraftment Enhancers

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2487-2490

2008

  1. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: Role of human leukocyte antigen compatibility

    Liver Transplantation, Vol. 14, Núm. 4, pp. 554-562

2007

  1. Rapid molecular prenatal diagnosis of ataxia-telangiectasia by direct mutational analysis

    Prenatal Diagnosis, Vol. 27, Núm. 9, pp. 861-864

2005

  1. Rapid molecular diagnosis of ataxia-telangiectasia by optimised RT-PCR and direct sequencing analysis

    Immunobiology, Vol. 210, Núm. 5, pp. 279-282

1998

  1. Transcription and weak expression of HLA-DRB6: A gene with anomalies in exon 1 and other regions

    Immunogenetics, Vol. 48, Núm. 1, pp. 16-21